Feature Articles

Feature Articles

ASH Clinical News takes a deeper look at hot topics in medicine

Conflict Resolution: Research Under the Influence

In an ideal world, medical advances would result from an altruistic pairing of outstanding translational science with well-designed and efficient clinical trials, and the...

Blood Donation: Separating Myth From Fact

After natural disasters and other tragic events, many people try to help by rushing to the nearest blood donation center. While there’s no denying...

Gun Violence: A Public Health Crisis

Does the oath to “do no harm” conflict with the right to bear arms? Issues related to gun violence and regulation are among the most...

What are Biosimilars?

Defining the new category and exploring physicians’ attitudes about biosimilars in the marketplace A growing number of biosimilars are making their way through the drug...

Demystifying Gene Editing With CRISPR

Gene editing has received a great deal of media attention in recently due to its potential for advancing science and treating disease. In a...

The Big Business of Biosimilars

Uptake of biosimilars to the market – and the potential savings – will depend on physician education and confidence. To gain approval from the U.S....

High Hopes

Hematology patients are turning to cannabis for symptom relief, but should they? As of October 2017, 28 states and the District of Columbia had...

A World of Difference

The slow march to bring high-quality hematology and oncology care to limited-resource areas The pace of progress in hematology and oncology treatment is dizzying,...

A Behind-the-Scenes Look at the ASH Annual Meeting

Every December, tens of thousands of researchers, clinicians, and health-care stakeholders gather for the American Society of Hematology’s (ASH) annual meeting. More than a...

Off to the CAR T Races: Bringing CAR T-Cell Therapies to Cancer Patients

August 30, 2017, marked a milestone for medicine: The cell-based gene therapy tisagenlecleucel became the first U.S. Food and Drug Administration (FDA)–approved treatment that...
Advertisement

Current Issue

February 2018 Volume 4, Issue 3

This issue features a conversation with National Cancer Institute Director Norman “Ned” Sharpless, MD, a look at the prevalence and controversial nature of academic-industry partnerships, and more.